NCT05071248 (MobiStaR) is a NA clinical trial of VEMO (Reactive Robotics GmbH) in Patient Activation, sponsored by Ludwig-Maximilians - University of Munich.

Who is sponsoring NCT05071248?

NCT05071248 is sponsored by Ludwig-Maximilians - University of Munich.

What drugs are being tested in NCT05071248?

Interventions in NCT05071248: VEMO (Reactive Robotics GmbH).

What condition does NCT05071248 study?

NCT05071248 studies Patient Activation, Mobilization, Robotics.

Is NCT05071248 still recruiting?

NCT05071248 is currently completed. Last updated 11 October 2023.

Last reviewed 2023-10-11 · How we verify

NCT05071248: MobiStaR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect of Robot-assisted Early Mobilization - Project MobiStaR

Completed NA Last updated 11 October 2023

What this trial tests

NA trial testing VEMO (Reactive Robotics GmbH) in Patient Activation in 23 participants. Completed in 15 May 2022.

Timeline

15 September 2021

Primary endpoint
15 April 2022

15 May 2022

Quick facts

Lead sponsor	Ludwig-Maximilians - University of Munich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	supportive care
Enrollment	23
Start date	15 September 2021
Primary completion	15 April 2022
Estimated completion	15 May 2022
Sites	1 location across Germany

Drugs / interventions tested

VEMO (Reactive Robotics GmbH)

Conditions studied

Patient Activation — all drugs for Patient Activation →
Mobilization — all drugs for Mobilization →
Robotics — all drugs for Robotics →

Sponsor

Ludwig-Maximilians - University of Munich

Who can join

18 and older, any sex, with Patient Activation or Mobilization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Within the MobiStaR project the adaptation of procedures in an intensive care unit combined with the use of this robotic system will create the conditions to increase the mobilization rate of critically ill intensive care patients significantly, possibly thereby increasing the rehabilitation outcomes for these patients and developing a new standard of care for robot-assisted early mobilization. The intervention study will assess the organizational feasibility of robot-assisted early mobilization (starting in the first 72 hours after admission to the ICU), the behavior and experience of the mobilizing professionals and the effects on patient outcomes in terms of ventilation time, muscle mass (sonographic examination) and physical activity (measured by established scores such as Functional Status Score for ICU (FSS-ICU) and Medical Research Council (MRC) classification).

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of robotic-assisted early mobilization versus conventional mobilization in intensive care unit patients: prospective interventional cohort study with retrospective control group analysis.
Huebner L, Warmbein A, Scharf C, Schroeder I, et al · · 2024 · cited 9× · PMID 38582934 · DOI 10.1186/s13054-024-04896-1
Robot-assisted early mobilization for intensive care unit patients: Feasibility and first-time clinical use.
Warmbein A, Hübner L, Rathgeber I, Mehler-Klamt AC, et al · · 2024 · cited 6× · PMID 38350342 · DOI 10.1016/j.ijnurstu.2024.104702
Robot-assisted early mobilization of intensive care patients: a feasibility study protocol.
Warmbein A, Schroeder I, Mehler-Klamt A, Rathgeber I, et al · · 2022 · cited 4× · PMID 36333746 · DOI 10.1186/s40814-022-01191-0
Effects of robotic-assisted early mobilization versus conventional mobilization in intensive care unit patients: The MobiStaR trial
Huebner L, Warmbein A, Scharf C, Schroeder I, et al · · 2023 · DOI 10.21203/rs.3.rs-3695698/v1
Can mobilising specialists be relieved by a robotic system for the early mobilisation of intensive-care patients? A quantitative longitudinal study at three data collection points at a German university hospital
Mehler-Klamt A, Koestler N, Huber J, Warmbein A, et al · · 2023 · DOI 10.21203/rs.3.rs-3135275/v2
Robot-assisted mobilisation in the intensive care unit - does it offer relief to mobilising specialists? A qualitative longitudinal study at three data collection points at a German university hospital
Mehler-Klamt AC, Huber J, Köstler N, Warmbein A, et al · · 2023 · DOI 10.21203/rs.3.rs-3200143/v1
Evaluation of effects of robot-assisted early mobilization on critically ill patients, on the mobilization behaviour and experience of the mobilizing professionals and the organizational processes in an intensive care unit - a clinical intervention study: study protocol
Warmbein A, Schroeder I, Mehler-Klamt AC, Rathgeber I, et al · · 2022 · DOI 10.21203/rs.3.rs-1339805/v1

Verify or expand the search:

Other recruiting trials for Patient Activation

Currently open trials in the same condition.

NCT06973954 — Improving the Activation Level of Diabetic Individuals · NA · active not recruiting
NCT05989477 — At-home Breast Oncology Care Delivered With E-health Solutions · NA · recruiting
NCT05263310 — Prepare for Your Diabetes Care · NA · active not recruiting

Other Ludwig-Maximilians - University of Munich trials

Trials by the same sponsor.

NCT07514520 — Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION · active not recruiting
NCT07504965 — Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly · recruiting
NCT07100548 — A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media · completed
NCT07061600 — Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media · NA · completed
NCT06749106 — Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05071248 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ludwig-Maximilians - University of Munich
Last refreshed: 11 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing